Trial Profile
A Pilot Study of Chemoradiotherapy Plus Temsirolimus (Torisel) for Advanced Head and Neck Cancer.
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase I
Latest Information Update: 25 Oct 2016
Price :
$35
*
At a glance
- Drugs Temsirolimus (Primary) ; Cetuximab; Cisplatin
- Indications Head and neck cancer
- Focus Adverse reactions
- 14 Feb 2012 Status changed from recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 04 Apr 2011 New trial record